These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17146107)

  • 1. An antiproliferative genetic screening identifies a peptide aptamer that targets calcineurin and up-regulates its activity.
    de Chassey B; Mikaelian I; Mathieu AL; Bickle M; Olivier D; Nègre D; Cosset FL; Rudkin BB; Colas P
    Mol Cell Proteomics; 2007 Mar; 6(3):451-9. PubMed ID: 17146107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin A versus NS5A-TP2/HD domain containing 2: a case study of site-directed low-frequency random mutagenesis for dissecting target specificity of peptide aptamers.
    Dibenedetto S; Cluet D; Stebe PN; Baumle V; Léault J; Terreux R; Bickle M; Chassey BD; Mikaelian I; Colas P; Spichty M; Zoli M; Rudkin BB
    Mol Cell Proteomics; 2013 Jul; 12(7):1939-52. PubMed ID: 23579184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures.
    Bickle MB; Dusserre E; Moncorgé O; Bottin H; Colas P
    Nat Protoc; 2006; 1(3):1066-91. PubMed ID: 17406388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide aptamer libraries.
    Borghouts C; Kunz C; Groner B
    Comb Chem High Throughput Screen; 2008 Feb; 11(2):135-45. PubMed ID: 18336207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide aptamers: development and applications.
    Reverdatto S; Burz DS; Shekhtman A
    Curr Top Med Chem; 2015; 15(12):1082-101. PubMed ID: 25866267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic effect of disulfide-rich peptide aptamers selected by cDNA display on interleukin-6-dependent cell proliferation.
    Nemoto N; Tsutsui C; Yamaguchi J; Ueno S; Machida M; Kobayashi T; Sakai T
    Biochem Biophys Res Commun; 2012 Apr; 421(1):129-33. PubMed ID: 22503683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-regulated peptide aptamers.
    Miller RA
    Methods Mol Biol; 2009; 535():315-31. PubMed ID: 19377988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of Peptide aptamers to target protein function.
    Lopez-Ochoa L; Nash TE; Ramirez-Prado J; Hanley-Bowdoin L
    Methods Mol Biol; 2009; 535():333-60. PubMed ID: 19377987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial library of improved peptide aptamers, CLIPs to inhibit RAGE signal transduction in mammalian cells.
    Reverdatto S; Rai V; Xue J; Burz DS; Schmidt AM; Shekhtman A
    PLoS One; 2013; 8(6):e65180. PubMed ID: 23785412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of vaccinia virus replication by peptide aptamers.
    Saccucci L; Crance JM; Colas P; Bickle M; Garin D; Iseni F
    Antiviral Res; 2009 Jun; 82(3):134-40. PubMed ID: 19428604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
    Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
    Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to Taxol.
    Kunz C; Borghouts C; Buerger C; Groner B
    Mol Cancer Res; 2006 Dec; 4(12):983-98. PubMed ID: 17189388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide aptamers for small molecule drug discovery.
    Bardou C; Borie C; Bickle M; Rudkin BB; Colas P
    Methods Mol Biol; 2009; 535():373-88. PubMed ID: 19377984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Nr-13 antideath activity by peptide aptamers.
    Nouvion AL; Thibaut J; Lohez OD; Venet S; Colas P; Gillet G; Lalle P
    Oncogene; 2007 Feb; 26(5):701-10. PubMed ID: 16909120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide aptamers that bind to a geminivirus replication protein interfere with viral replication in plant cells.
    Lopez-Ochoa L; Ramirez-Prado J; Hanley-Bowdoin L
    J Virol; 2006 Jun; 80(12):5841-53. PubMed ID: 16731923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Random mutagenesis of peptide aptamers as an optimization strategy for inhibitor screening.
    Bouquier N; Fromont S; Debant A; Schmidt S
    Methods Mol Biol; 2012; 928():97-118. PubMed ID: 22956136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design and biophysical characterization of thioredoxin-based aptamers: insights into peptide grafting.
    Brown CJ; Dastidar SG; See HY; Coomber DW; Ortiz-Lombardía M; Verma C; Lane DP
    J Mol Biol; 2010 Jan; 395(4):871-83. PubMed ID: 19895821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide aptamers with biological and therapeutic applications.
    Li J; Tan S; Chen X; Zhang CY; Zhang Y
    Curr Med Chem; 2011; 18(27):4215-22. PubMed ID: 21838684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide aptamers expressed in the secretory pathway interfere with cellular PrPSc formation.
    Gilch S; Kehler C; Schätzl HM
    J Mol Biol; 2007 Aug; 371(2):362-73. PubMed ID: 17574575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide aptamers as guides for small-molecule drug discovery.
    Baines IC; Colas P
    Drug Discov Today; 2006 Apr; 11(7-8):334-41. PubMed ID: 16580975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.